Crocetina (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "Crocetina" in Galician language version.

refsWebsite

Global rank Galician rank

16doi.org

2^nd place

7^th place

15nih.gov

4^th place

6^th place

3web.archive.org

1^st place

2espacenet.com

800^th place

1,874^th place

1archive.org

6^th place

8^th place

1clinicaltrials.gov

5,225^th place

7,257^th place

1diffusionpharma.com

low place

archive.org

Mizuma H, Tanaka M, Nozaki S, Mizuno K, Tahara T, Ataka S, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (marzo de 2009). "Daily oral administration of crocetin attenuates physical fatigue in human subjects". Nutrition Research 29 (3): 145–50. PMID 19358927. doi:10.1016/j.nutres.2009.02.003.

clinicaltrials.gov

"Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)". ClinicalTrials.gov. novembro de 2011. Consultado o 18 de setembo de 2012.

diffusionpharma.com

investors.diffusionpharma.com

"Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS". Diffusion Pharmaceuticals. 5 de maio de 2020. Arquivado dende o orixinal o 17 de agosto de 2020. Consultado o 25 de maio de 2020.

doi.org

dx.doi.org

Umigai N, Murakami K, Ulit MV, et al. (maio de 2011). "The pharmacokinetic profile of crocetin in healthy adult human volunteers after a single oral administration". Phytomedicine 18 (7): 575–8. PMID 21112749. doi:10.1016/j.phymed.2010.10.019.
Ichi, T; Higashimura, Y; Katayama, T; Koda, T; Shimizu, T; Tada, M (1995). "Analysis of Crocetin Derivatives from Gardenia". Nippon Shokuhin Kagaku Kogaku Kaishi 42 (10): 776–783. doi:10.3136/nskkk.42.776.
Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, Hong JW, Lee EH (2010). "Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells.". European Journal of Pharmacology 648 (1–3): 110–6. PMID 20854811. doi:10.1016/j.ejphar.2010.09.003.
Mizuma H, Tanaka M, Nozaki S, Mizuno K, Tahara T, Ataka S, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (marzo de 2009). "Daily oral administration of crocetin attenuates physical fatigue in human subjects". Nutrition Research 29 (3): 145–50. PMID 19358927. doi:10.1016/j.nutres.2009.02.003.
Kuratsune H, Umigai N, Takeno R, Kajimoto Y, Nakano T (setembro de 2010). "Effect of crocetin from Gardenia jasminoides Ellis on sleep: a pilot study". Phytomedicine 17 (11): 840–3. PMID 20537515. doi:10.1016/j.phymed.2010.03.025.
Yamauchi, M; Tsuruma, K; Imai, S; Nakanishi, T; Umigai, N; Shimazawa, M; Hara, H (2011). "Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity". European Journal of Pharmacology 650 (1): 110–9. PMID 20951131. doi:10.1016/j.ejphar.2010.09.081.
Gainer, J (2008). "Trans-sodium crocetinate for treating hypoxia/ischemia". Expert Opinion on Investigational Drugs 17 (6): 917–924. PMID 18491992. doi:10.1517/13543784.17.6.917.
Giassi L; et al. (2001). "Trans-Sodium Crocetinate Restores Blood Pressure, Heart Rate, and Plasma Lactate after Hemorrhagic Shock". Journal of Trauma-Injury Infection & Critical Care 51 (5): 932–938. PMID 11706343. doi:10.1097/00005373-200111000-00018.
Lapchak P (2010). "Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: A combination therapy study with tissue plasminogen activator". Brain Research 1309: 136–145. PMID 19891959. doi:10.1016/j.brainres.2009.10.067.
Mohler E; et al. (2010). "Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication". Vascular Medicine 16 (5): 346–352. PMC 4182020. PMID 22003000. doi:10.1177/1358863X11422742.
Stennett a; et al. (2006). "Trans sodium crocetinate and diffusion enhancement". The Journal of Physical Chemistry B 110 (37): 18078–18080. PMID 16970413. doi:10.1021/jp064308+.
Laidig, K.E.; J.L. Gainer; V. Daggett (1998). "Altering Diffusivity in Biological Solutions through Modification of Solution Structure and Dynamics". Journal of the American Chemical Society 120 (36): 9394–9395. doi:10.1021/ja981656j.
Manabe H; et al. (2010). "Protection against focal ischemic injury to the brain by trans-sodium crocetinate". Journal of Neurosurgery 113 (4): 802–809. PMC 3380430. PMID 19961314. doi:10.3171/2009.10.JNS09562.
Berger F, Hensel A, Nieber K (2011). "Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices". Neuroscience 180: 238–47. PMID 21352900. doi:10.1016/j.neuroscience.2011.02.037.
Lautenschläger M, Lechtenberg M, Sendker J, Hensel A (2014). "Effective isolation protocol for secondary metabolites from saffron: semi-preparative scale preparation of crocin-1 and trans-crocetin". Fitoterapia 92: 290–5. PMID 24321578. doi:10.1016/j.fitote.2013.11.014.
Lautenschläger M, Sendker J, Hüwel S, Galla HJ, Brandt S, Düfer M, Riehemann K, Hensel A (2015). "Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier". Phytomedicine 22 (1): 36–44. PMID 25636868. doi:10.1016/j.phymed.2014.10.009.

espacenet.com

worldwide.espacenet.com

US patent 8,206,751 Arquivado 30 de decembro de 2023 en Wayback Machine., Gainer J, "New Class of Therapeutics that Enhance Small Molecule Diffusion", issued 2009-04-30
US patent 6,060,511 Arquivado 30 de decembro de 2023 en Wayback Machine., Gainer J, "Trans-sodium crocetinate, methods of making and methods of use thereof", issued 2000-05-09

nih.gov

ncbi.nlm.nih.gov

Umigai N, Murakami K, Ulit MV, et al. (maio de 2011). "The pharmacokinetic profile of crocetin in healthy adult human volunteers after a single oral administration". Phytomedicine 18 (7): 575–8. PMID 21112749. doi:10.1016/j.phymed.2010.10.019.
Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, Jung WS, Cho KH, Park JH, Kang I, Hong JW, Lee EH (2010). "Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells.". European Journal of Pharmacology 648 (1–3): 110–6. PMID 20854811. doi:10.1016/j.ejphar.2010.09.003.
Mizuma H, Tanaka M, Nozaki S, Mizuno K, Tahara T, Ataka S, Sugino T, Shirai T, Kajimoto Y, Kuratsune H, Kajimoto O, Watanabe Y (marzo de 2009). "Daily oral administration of crocetin attenuates physical fatigue in human subjects". Nutrition Research 29 (3): 145–50. PMID 19358927. doi:10.1016/j.nutres.2009.02.003.
Kuratsune H, Umigai N, Takeno R, Kajimoto Y, Nakano T (setembro de 2010). "Effect of crocetin from Gardenia jasminoides Ellis on sleep: a pilot study". Phytomedicine 17 (11): 840–3. PMID 20537515. doi:10.1016/j.phymed.2010.03.025.
Yamauchi, M; Tsuruma, K; Imai, S; Nakanishi, T; Umigai, N; Shimazawa, M; Hara, H (2011). "Crocetin prevents retinal degeneration induced by oxidative and endoplasmic reticulum stresses via inhibition of caspase activity". European Journal of Pharmacology 650 (1): 110–9. PMID 20951131. doi:10.1016/j.ejphar.2010.09.081.
Gainer, J (2008). "Trans-sodium crocetinate for treating hypoxia/ischemia". Expert Opinion on Investigational Drugs 17 (6): 917–924. PMID 18491992. doi:10.1517/13543784.17.6.917.
Giassi L; et al. (2001). "Trans-Sodium Crocetinate Restores Blood Pressure, Heart Rate, and Plasma Lactate after Hemorrhagic Shock". Journal of Trauma-Injury Infection & Critical Care 51 (5): 932–938. PMID 11706343. doi:10.1097/00005373-200111000-00018.
Lapchak P (2010). "Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: A combination therapy study with tissue plasminogen activator". Brain Research 1309: 136–145. PMID 19891959. doi:10.1016/j.brainres.2009.10.067.
Mohler E; et al. (2010). "Evaluation of trans sodium crocetinate on safety and exercise performance in patients with peripheral artery disease and intermittent claudication". Vascular Medicine 16 (5): 346–352. PMC 4182020. PMID 22003000. doi:10.1177/1358863X11422742.
Stennett a; et al. (2006). "Trans sodium crocetinate and diffusion enhancement". The Journal of Physical Chemistry B 110 (37): 18078–18080. PMID 16970413. doi:10.1021/jp064308+.
Manabe H; et al. (2010). "Protection against focal ischemic injury to the brain by trans-sodium crocetinate". Journal of Neurosurgery 113 (4): 802–809. PMC 3380430. PMID 19961314. doi:10.3171/2009.10.JNS09562.
Berger F, Hensel A, Nieber K (2011). "Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices". Neuroscience 180: 238–47. PMID 21352900. doi:10.1016/j.neuroscience.2011.02.037.
Lautenschläger M, Lechtenberg M, Sendker J, Hensel A (2014). "Effective isolation protocol for secondary metabolites from saffron: semi-preparative scale preparation of crocin-1 and trans-crocetin". Fitoterapia 92: 290–5. PMID 24321578. doi:10.1016/j.fitote.2013.11.014.
Lautenschläger M, Sendker J, Hüwel S, Galla HJ, Brandt S, Düfer M, Riehemann K, Hensel A (2015). "Intestinal formation of trans-crocetin from saffron extract (Crocus sativus L.) and in vitro permeation through intestinal and blood brain barrier". Phytomedicine 22 (1): 36–44. PMID 25636868. doi:10.1016/j.phymed.2014.10.009.

pubchem.ncbi.nlm.nih.gov

CID 5281232 de PubChemErro de script: Non existe o módulo «WikidataCheck».

web.archive.org

US patent 8,206,751 Arquivado 30 de decembro de 2023 en Wayback Machine., Gainer J, "New Class of Therapeutics that Enhance Small Molecule Diffusion", issued 2009-04-30
US patent 6,060,511 Arquivado 30 de decembro de 2023 en Wayback Machine., Gainer J, "Trans-sodium crocetinate, methods of making and methods of use thereof", issued 2000-05-09
"Diffusion Pharmaceuticals Announces FDA Accelerated Review of TSC Clinical Development Plan to Treat COVID-19 Patients with ARDS". Diffusion Pharmaceuticals. 5 de maio de 2020. Arquivado dende o orixinal o 17 de agosto de 2020. Consultado o 25 de maio de 2020.